Cresco Labs Inc. (CRLBF) stock
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Earnings
Cresco Labs's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q4 FY2024
$176.00M
-6.4% on a year earlier
EPS, Q4 FY2024
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Cresco Labs's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2024ended Dec 31, 2024 | Mar 12, 2025during market hours | $176.00M | -6.4% | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 13, 2024during market hours | $188.00M | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 16, 2023after the close | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Apr 1, 2022during market hours | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Cresco Labs has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Cresco Labs puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Cresco Labs filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?